Enantios Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Series 1

  • Latest Deal Amount
  • $7M

  • Investors
  • 11

Enantios General Information

Description

Developer of molecular measurement technology designed to accelerate drug discovery and pharmaceutical manufacturing. The company leverages advanced characterization tools to determine the structure of complex chiral molecules and biologics, enabling pharmaceutical researchers to understand molecular interactions and optimize production processes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Räffelstrasse 24, LEE P 208
  • 8045 Zurich
  • Switzerland
Primary Industry
Other Healthcare Technology Systems
Other Industries
Electronic Equipment and Instruments
Vertical(s)
Corporate Office
  • Räffelstrasse 24, LEE P 208
  • 8045 Zurich
  • Switzerland

Enantios Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Enantios Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Early Stage VC (Series 1) 31-Jan-2026 $7M Completed Generating Revenue
9. Accelerator/Incubator 01-Jan-2026 Completed Generating Revenue
8. Accelerator/Incubator 24-Feb-2025 Completed Generating Revenue
7. Seed Round 27-Jun-2024 Completed Generating Revenue
6. Grant Completed Generating Revenue
5. Accelerator/Incubator Completed Generating Revenue
4. Seed Round 05-Apr-2023 Completed Generating Revenue
3. Accelerator/Incubator 18-Jan-2023 Completed Generating Revenue
2. Grant 10-Jan-2023 $10.8K Completed Generating Revenue
1. University Spin-Out 01-Dec-2022 Completed Startup
To view Enantios’s complete valuation and funding history, request access »

Enantios Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 Shares
Seed 1 Shares
To view Enantios’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Enantios Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular measurement technology designed to accelerate drug discovery and pharmaceutical manufacturing. Th
Other Healthcare Technology Systems
Zurich, Switzerland
9 As of 2025

Kyoto, Japan
 

San Francisco, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Enantios Competitors (9)

One of Enantios’s 9 competitors is Horiba, a Corporation company based in Kyoto, Japan.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Horiba Corporation Kyoto, Japan
EMOTIV Venture Capital-Backed San Francisco, CA
JASCO Corporation Easton, MD
Biotools Corporation West Palm Beach, FL
Renishaw Corporation Wotton-under-Edge, United Kingdom
You’re viewing 5 of 9 competitors. Get the full list »

Enantios Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Enantios Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
EuroUS Ventures Venture Capital Minority
MedTech Innovator Accelerator/Incubator
Tech Tour Accelerator/Incubator
Privilège Ventures Venture Capital Minority
S2S Ventures Venture Capital Minority
You’re viewing 5 of 11 investors. Get the full list »

Enantios FAQs

  • When was Enantios founded?

    Enantios was founded in 2022.

  • Where is Enantios headquartered?

    Enantios is headquartered in Zurich, Switzerland.

  • What is the size of Enantios?

    Enantios has 9 total employees.

  • What industry is Enantios in?

    Enantios’s primary industry is Other Healthcare Technology Systems.

  • Is Enantios a private or public company?

    Enantios is a Private company.

  • What is Enantios’s current revenue?

    The current revenue for Enantios is .

  • How much funding has Enantios raised over time?

    Enantios has raised $10.3M.

  • Who are Enantios’s investors?

    EuroUS Ventures, MedTech Innovator, Tech Tour, Privilège Ventures, and S2S Ventures are 5 of 11 investors who have invested in Enantios.

  • Who are Enantios’s competitors?

    Horiba, EMOTIV, JASCO, Biotools, and Renishaw are some of the 9 competitors of Enantios.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process